Lupin recalls 17,814 bottles of Cefprozil in US market

26 Apr 2021 Evaluate

Lupin is recalling 17,814 bottles of Cefprozil for Oral Suspension USP, a second-generation antibiotic used to treat ear infections, skin infections, and other bacterial infections in US market. According to the USFDA, the company is recalling the affected lot for being ‘Superpotent’.

The affected lot has been manufactured at Lupin's Mandideep plant in Madhya Pradesh and distributed in the US by Baltimore-based Lupin Pharmaceuticals Inc. Lupin initiated the Class II voluntary recall across the US and Puerto Rico on March 26 this year.

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Share Price

2171.15 -7.05 (-0.32%)
20-Jan-2026 14:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1615.00
Dr. Reddys Lab 1174.70
Cipla 1382.70
Zydus Lifesciences 874.20
Lupin 2171.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×